ON-DEMAND PROGRAM & POSTER PRESENTATIONS
The on-demand and poster presentations for APSAD 2021 are grouped into 29 themes. Click on the headings/+ below to view the presentations from each theme.
To view the abstract, click on the title of the presentation.
PO= Poster Presentation | VP= Video Presentation | SYM= Symposium
Adolescents & Youth
VP#234: “I Think We’d Try And Delay It, And Try And Deflect It Or Wait For Another Day”: Parental Views About Supply Of Alcohol To Adolescents
Speaker: Nathan Harrison, South Australian Health And Medical Research Institute (SAHMRI)i), SA
VP#71: “Don’t Blame The Booze”: News Media Analysis Of Representations Of Parent’s Role On Youth Drinking In Australia
Speaker: Megan Cook, Centre For Alcohol Policy Research, La Trobe University, VIC
PO#293: Testing A Psychosocial Model Of Sexual Risk-Taking Among University-Based Adolescents
Speaker: Laura Anderson, NCYSUR, QLD
PO#299: A Peer-Support Mental Health Mobile Application For Adolescents: Development Of The Mind Your Mate Program
Speaker: Ainsley Furneaux-Bate, The Matilda Centre for Research in Mental Health and Substance Use, NSW
PO#150: Substance Use And Comorbid Psychopathology Characteristics In Young Treatment-Seeking Substance Users: A Latent Class Analysis
Speaker: Valeriya Mefodeva, University of Queensland, QLD
PO#66: DSM-5 And ICD-11 Alcohol Use Disorder Criteria In Young Adult Regular Drinkers: Lifetime Prevalence And Age Of Onset
Speaker: Siobhan O’Dean, The Matilda Centre For Substance Use And Mental Health Research, NSW
Aetiology, Genetics & Neuroscience
PO#27: A Novel Genotype In Patients With Alcohol Use Disorder
Speaker: Meryem Jefferies, Western Sydney Local Health District Drug Health, NSW
PO#29: Genetic Risk Factors In Patients With Alcohol-Related Liver Disease
Speaker: Meryem Jefferies, Western Sydney Local Health District Drug Health, NSW
PO#69: Can The OPRM1 Gene Predict Risk For Opioid Misuse? A Human Laboratory Examination
Speaker: Kelly Dunn, Johns Hopkins University, USA
PO#193: Inhibition Of The Mechanistic Target Of Rapamycin Complex 1 Signalling Pathway For Treatment Of Moderate-Severe Alcohol Use Disorder – An Early Phase Safety And Feasibility Pilot Study
Speaker: Amanda Brown, Hunter New England Local Health District, Drug & Alcohol Clinical Services, NSW
PO#114: Impaired Habit Formation Prevents Adaptive Decision-Making In People With Methamphetamine Use Disorder
Speaker: Alex Robinson, Monash University, VIC
PO#204: A Randomised, Double-Blind Study Investigating The Relationship Between Early Childhood Trauma And The Rewarding Effects Of Morphine
Speaker: Molly Carlyle, University Of Queensland, QLD
Alcohol
VP#307 “No programmers and must be cheap” – Improving assessment and progress monitoring in alcohol use disorder treatment
Speaker: Matthew Gullo, Mrff Trip Principal Research Fellow, NCYSUR
PO#42: Estimating The Global Treatment Rates For Alcohol Use Disorder And Depression: A Systematic Review And Meta-Analysis
Speaker: Tesfa Mekonen Yimer, School Of Psychology, The University Of Queensland, QLD
PO#88: The Changing Profile Of Risky Alcohol Consumption Between 2001 And 2019: Women Aged 40 And Older
Speaker: Parker Blakey, Australian Institute Of Health And Welfare, ACT
PO#239: Which Drinkers Change Their Alcohol Consumption Due To Energy Content Concerns?
Speaker: Jacqueline Bowden, University of Adelaide; South Australian Health and Medical Research Institute (SAHMRI), SA
PO#196: Personality Traits As Predictors Of Pre-Drinking Levels
Speaker: Dominique De Andrade, Deakin University, QLD
PO#145: “Let’s Get Drunk And Blackout”: When Are Alcohol-Related And Alcohol-Related Blackout Tweets Written In The United States?
Speaker: Benjamin Riordan, La Trobe University, NZ
BBV
VP#144: Hepatitis C Education In Drug And Alcohol Settings: Preliminary Evaluation Findings From A National Online Training Program
Speaker: Olivia Dawson, ASHM, NSW
VP#318: Peer Specialists Working In Partnership With Clinical Staff To Enhance Hepatitis C Testing And Treatment Among People Who Inject Drugs: Peer Experiences From The PATH-Expanded Model
Speaker: Daniel O’Keefe, Burnet Institute, VIC
VP#105: Setting Foot In Private Spaces: Extending The Hepatitis C Cascade Of Care To Automatic Needle/Syringe Dispensing Machines
Speaker: Carolyn Day, University Of Sydney, NSW
PO#210: “But I Don’t Inject” Misconceptions From Clinicians About Sexually Transmitted Infections And Blood Borne Viruses In Drug And Alcohol Users
Speaker: Denise Irvin, NLSHD, NSW
PO#306: Exploring Hepatitis C Virus Testing And Treatment Engagement Over Time In Melbourne, Australia: A Study Protocol For The EC-Experience Prospective Cohort Study
Speaker: Jack Gunn, Burnet Institute, VIC
PO#349: Hepatitis C Treatment Outcomes During The DAA Era Within A Community-Based Service For People Who Inject Drugs: Results For The Queensland Injectors Health Network Treatment And Management Program, 2015-2021
Speaker: Andrew Smirnov, The University Of Queensland, QLD
PO#83: Declining Prevalence Of Current HCV Infection Associated With Increased Treatment Uptake Among People Who Inject Drugs: The ETHOS Engage Study
Speaker: Heather Valerio, The Kirby Institute, NSW
Cannabis
VP#133: Cannabis Vaping: A Systematic Review And Meta-Analysis Of Its Sociodemographic, Behavioural And Psychological Correlates
Speaker: Jack Yiu Chak Chung, National Centre for Youth Substance Use Research (NCYSUR), QLD
VP#188: How Many People Use Cannabis For Medicinal Reasons In Australia?
Speaker: Janni Leung, National Centre for Youth Substance Use Research (NCYSUR), The University of Queensland, QLD
VP#74: Prevalence And Correlates Of Cannabis Use Disorder Among Australian Medical Cannabis Users
Speaker: Llewellyn Mills, Drug And Alcohol Services, South Eastern Sydney Local Health District, NSW
PO#294: Prevalence And Correlates Of Early-Onset Cannabis Use In Aotearoa New Zealand
Speaker: Jude Ball, University of Otago, Wellington, NZ
PO#198: Cannabis-Induced Dysphoria/Paranoia Mediates The Link Between Childhood Trauma And Psychotic-Like Experiences In Young Cannabis Users
Speaker: Molly Carlyle, University Of Queensland, QLD
PO#127: How Much Cannabis Is Used In A Joint? An Exploratory Investigation Into Typical Use, Adjustments For Potency And Behavioural Correlates
Speaker: Danielle Dawson, National Centre for Youth Substance Use Research (NCYSUR), QLD
PO#141: Identifying And Reproducing Common Home Methods Of Creating Cannabis Extracts For Vaporisation
Speaker: Grace Gshwend, University of Wollongong, NSW
PO#194: The Effects Of Cannabis Use On The Development Of Adolescents And Young Adults
Speaker: Janni Leung, National Centre for Youth Substance Use Research (NCYSUR), The University of Queensland, QLD
PO#107: Prevalence And Reasons Of Medicinal Cannabis Use – Findings From The International Cannabis Policy Study 2018
Speaker: Janni Leung, National Centre for Youth Substance Use Research (NCYSUR), The University of Queensland, QLD
PO#1: Perceptions Of And Attitudes Towards Medicinal Cannabis: A Systematic Literature Review
Speaker: Shivon Singh, Fairfield Hospital, NSW
PO#75: Friend Or Foe: Is Cannabis Use Associated With A Reduction In Heroin Use Over 20-Years?
Speaker: Jack Wilson, The Matilda Centre, University Of Sydney, NSW
#PO84 Cannabis and Cocaine: New Challenges for Australian Workplaces
Speaker: Ann Roche, Director, Flinders University
Children, Families & Friends
VP#85: Stepping Stones Program – The Family Perspective
Speaker: Anna Daglish, Family Drug Support, QLD
PO#174: Developing A Family And Friends Focused Outcomes Framework For Information And Support Services
Speaker: Jane Fischer, National Centre for Education and Training on Addiction (NCETA), Flinders University, SA
PO#108: Enhancing Access To Support Services For Families And Friends Of People With Alcohol Or Drug Concerns: Barriers, Facilitators And Recommendations
Speaker: Siyu Qian, Drug And Alcohol Service, Illawarra Shoalhaven Local Health District, NSW
PO#341: Information And Support Service Needs Of Family And Friends Of People Who Use Alcohol & Other Drugs
Speaker: Craig Martin, Alcohol And Drug Foundation, NSW
Comorbidity
PO#99: Patient Reported Substance Use And Comorbidities Associated With Cannabis Use Among Clients Receiving Opioid Agonist Treatment
Speaker: Laila Parvaresh, South Eastern Sydney- Drug And Alcohol Services, NSW
PO#143: Pilot Feasibility Trial Of Cognitive Processing Therapy For Young People With Comorbid Posttraumatic Stress And Substance Use Disorders In Residential Substance Use Treatment
Speaker: Valeriya Mefodeva, The University Of Queensland, QLD
PO#284: The Quihn COVID-19 Psychiatry Telehealth Project: Pilot Study Of Case Conferencing To Improve Outcomes For People With Dual Diagnosis
Speaker: Andrew Smirnov, The University Of Queensland, QLD
PO#43: Co-Morbid Mental Health And Alcohol And Other Drugs – Is It Still In The Too Hard Basket?
Speaker: Sandra Sunjic, Drug & Alcohol Services, South Eastern Sydney Local Health District And Discipline Of Addiction Medicine, the University of Sydney, NSW
PO#109: Using Clinical Documentation To Understand Inclusion Of Trauma-Related Comorbidities In Substance Use Treatment
Speaker: Logan Harvey, The Matilda Centre, QLD
PO#38: The Risk Of Khat (Catha Edulis) Chewing For Common Mental Disorders: Cohort Study
Speaker: Habte Belete, The University of Queensland, QLD
COVID-19
PO#314: The Relationship Between Risky Alcohol Consumption, Loneliness And Social Group Membership During COVID-19
Speaker: Marlee Bower, The University Of Sydney, NSW
PO#25: COVID-19 Impact On Drug Health Australian Indigenous And Non-Indigenous Patients
Speaker: Meryem Jefferies, Western Sydney Local Health District Drug Health, NSW
PO#225: Changing Risky Alcohol Use – Data Driven Campaigns During COVID And Beyond
Speaker: Cinzia Marrocco, Alcohol and Drug Foundation, VIC
PO#235: The Impact Of The COVID-19 Pandemic On AOD Staff, Clients, And Services
Speaker: Grace Newland, The University Of Queensland, QLD
PO#20: Shifts In Cannabis Use And Outcomes At The Onset Of The COVID-19 Pandemic And Associated Restrictions In 13 Countries
Speaker: Cheneal Puljević, The University Of Queensland, QLD
PO#334: Experiences Of Opioid Substitution Therapy During COVID-19: Insights From A ‘Big-Qual’ Analysis Of Online Community For A
Speaker: Anthony Barnett, Turning Point, VIC
PO#177: Preliminary Qualitative Findings Of The “Code” Study Of The Impacts Of Covid-19 On People Who Use Drugs
Speaker: Shelley Walker, Burnet Institute, VIC
PO#125: Australian Media Coverage Of Alcohol And Other Drug Consumption During COVID-19
Speaker: Filip Djordjevic, Centre for Alcohol Policy Research, VIC
FASD
PO#365: Cardiovascular And Metabolic Risk In Adults With Fetal Alcohol Spectrum Disorder And Its Link To Neurobehavioural Function
Speaker: Julie Kable, Emory University School Of Medicine, USA
PO#329: Fetal Alcohol Spectrum Disorder Australian Registry: Paediatric Research Informing Policy And Practice
Speaker: Melissa Mei Yin Cheung, The University of Sydney, NSW
PO#326: Ear Abnormalities Among Children With Fetal Alcohol Spectrum Disorder: A Systematic Review And Meta-Analysis
Speaker: Melissa Mei Yin Cheung, The University of Sydney, NSW
PO#364: Altered Bone Mineral Content And Body Composition In Children And Adolescents With Confirmed Prenatal Alcohol Exposure
Speaker: Sophia Young, University Of Queensland, QLD
Presentation 1: Clinical Characteristics And Diagnostic Outcomes Of Young Children With Prenatal Alcohol Exposure
Speaker: Sharon Dawe, Griffith University, QLD
Presentation 2: Interventions For Improving Executive Functions In Children With Fetal Alcohol Spectrum Disorder: Systematic Review And Meta-Analysis
Speaker: Joseph Lee Betts, Griffith University, QLD
Presentation 3: Understanding Sleep Problems In Children With Prenatal Alcohol Exposure: Implications For A Clinical Trial
Speaker: Ned Chandler-Mather, Griffith University, QLD
Presentation 4: Challenges In Assessing Young Children For Fetal Alcohol Spectrum Disorder And A Proposed Solution
Speaker: Elizabeth Eggins
Gambling
PO#292: Gambling In Australia During COVID-19
Speaker: Rebecca Jenksinson, Australian Gambling Research Centre, Australian Institute of Family Studies, VIC
PO#286: Gambling Trends Study: Piloting A National Gambling Reporting System
Speaker: Rebecca Jenksinson, Australian Gambling Research Centre, Australian Institute of Family Studies, VIC
Harm Reduction
VP#205: Barriers To Seeking Help Among Music Festival Attendees In New South Wales, Australia
Speaker: Robert Page, St Vincent’s Hospital Sydney, NSW
VP#97: High-Dose MDMA Drug Alerts And MDMA Use Intentions In Australia: A Quasi-Experimental Study
Speaker: Joel Keygan, University Of Tasmania, TAS
PO#254: A Systematic Review Of Interventions To Reduce Harms Associated With Alcohol And Other Drug Use In Licensed Entertainment Settings And Outdoor Music Festivals
Speaker: Christopher Eassey, National Drug And Alcohol Research Centre, NSW
PO#237: The Experiences Of Participation In The Supermix Study: A Qualitative Investigation
Speaker: Bebe Berryman, La Trobe University, VIC
PO#129: Prevalence Of Alcohol And Other Drug Use In Non-Transport Injury Events: A Systematic Review
Speaker: Georgina Lau, Monash University, VIC
PO#262: Minimising The Harm Of Illicit Drug Use Among Young Adults — Exploring The Data And The Strategies That Work
Speaker: Craig Martin, Alcohol And Drug Foundation, NSW
PO#21: The Measurement Of Receptive Needle And Syringe Sharing Among People Who Inject Drugs: Discussion And Evaluation
Speaker: Daniel O’Keefe, Burnet Institute, VIC
PO#103: Does Naloxone Provision Lead To Increased Substance Use? A Systematic Review To Assess If There Is Evidence Of A ‘Moral Hazard’ Associated With Naloxone Supply
Speaker: Wai Chung Tse, Monash Addiction Research Centre, VIC
PO#190: Patterns Of Recreational Nitrous Oxide Use And Harms In Australia
Speaker: Rachel Sutherland, NDARC, NSW
PO#207: What Aspects Of A Drug Checking Service Are Important For Australians Who Use Ecstasy?
Speaker: Raimondo Bruno, University Of Tasmania, TAS
PO#272: Limited Evidence Via Urinalysis Of Unintentional Fentanyl Use Among People Who Regularly Inject Opioids In Sydney And Melbourne
Speaker: Tina Lam, Monash Addiction Research Centre, VIC
Methamphetamine
Presentation 1: Testing New Medications For Stimulant Use Disorder Methamphetamine Type In Young People
Speaker: Gillinder Bedi, University Of Melbourne, VIC
Presentation 2: Predicting Reductions In Methamphetamine Use In The N-Ice Trial: A Randomised Controlled Trial Of N-Acetyl Cysteine For Methamphetamine Dependence
Speaker: Rebecca Mcketin, National Drug and Alcohol Research Centre, NSW
Presentation 3: Covid And The Lima Study, A Randomised, Double-Blind, Placebo Controlled Trial Of Lisdexamfetamine For The Treatment Of Methamphetamine Dependence
Speaker: Nadine Ezard, NCCRED, NSW
Presentation 4: The Future Of Pharmacotherapy Clinical Trials In Australia: The Olam Trial; The Moxy Trial; The Psima Trial; The Tina Trial
Speaker: Krista J. Siefried, NCCRED, NSW
PO#278: Theta Burst Transcranial Magnetic Stimulation (Tms) For Methamphetamine Use Disorder– A Feasibility Study To Inform The Design Of A Multisite Randomised Control Trial. Methods Poster
Speaker: Buddhima Lokuge, Drug And Alcohol Clinical Service, Hunter New England Local Health District, NSW
PO#166: Facilitating Engagement With Counselling For Methamphetamine Treatment: Perspectives Of Clinicians And Consumers
Speaker: Adam Rubenis, Turning Point, VIC
PO#377: A Clinical Research Network Approach To A Trial Of Oral Lisdexamfetamine For The Treatment Of Acute Methamphetamine Withdrawal
Speaker: Krista J Siefried, NCCRED, NSW
PO#68: Mental Health Service Utilisation Patterns In A Community Cohort Of People Who Primarily Smoke Methamphetamine
Speaker: Zoe Duncan, Monash University, VIC
PO#256: Pharmacological Treatment For Methamphetamine Withdrawal: A Systematic Review And Meta-Analysis Of Randomised Controlled Trials
Speaker: Liam Acheson, Unsw / St Vincent’s Hospital Sydney, NSW
PO#62: Starting Treatment In Public Drug And Alcohol Services In New South Wales (Nsw): What Can Emr Tell Us About Amphetamine Type Stimulant Use?
Speaker: Emma Black, The Langton Centre, NSW
PO#167: Drug-Driving Incidence In A High-Risk Cohort Of People Who Use Methamphetamine In Melbourne And Rural Victoria
Speaker: Paul Dietze, National Drug Research Institute, VIC
PO#77: Correlates Of Social Support Among Australians Who Primarily Smoke Methamphetamine
Speaker: Michael Leach, Monash University, VIC
PO#110: Towards An Australian Clinical Research Network For Methamphetamine And Emerging Drugs – Outcomes Of The Nccred Methamphetamine And Emerging Drugs Clinical Research Network Working Group 2018-21
Speaker: Krista J Siefried
PO#120: Development And Validation Of The Stimulant Refusal Self-Efficacy Questionnaire In Stimulant Users In Treatment
Speaker: Angela Wanigasooriya
PO#244: Investigating Acute Pathology Processes In MDMA-Related Deaths In Australia
Speaker: Amanda Roxburgh, Burnet Institute, NSW
PO#327 Development Of A Culturally Appropriate, National Website About Crystal Methamphetamine
Speaker: Steph Kershaw, University of Sydney, NSW
Opioid Agonist Treatment
Presentation 1:The Impact Of Covid-19 Upon Opioid Agonist Treatment Services In South-East Sydney, Australia: Outcomes For Clients And Implications For Ongoing Practices
Speaker: Rachel M. Deacon, The University Of Sydney, NSW
Presentation 2: Rethinking Opioid Treatment In Response To Covid-19: Co-Designing A New Model Of Care For Public Sector Opioid Services In South-East Sydney, Australia
Speaker: Kristie Mammen, COQI Program, DAS SESLHD, NSW
Presentation 3: The Covid-19 Risk Assessment Project: A Retrospective Analysis Of Service Delivery Changes To Opiate Treatment Delivery In Regional/Rural New South Wales
Speaker: Stacey Weedon, Hnelhd, NSW
VP#369: Coming Off Depot: Comparing Withdrawal From Depot Buprenorphine To Withdrawal From Sublingual Buprenorphine
Speaker: Llewellyn Mills, Drug And Alcohol Services, South Eastern Sydney Local Health District, NSW
PO#3: The Effect Of Person, Treatment And Prescriber Characteristics On Retention In Opioid Agonist Treatment: A 15-Year Retrospective Cohort Study
Speaker: Chrianna Bharat, National Drug & Alcohol Research Centre, WA
PO#376: Micro-Dosing With Buprenorphine To Transfer From Methadone To Buprenorphine – A Non-Randomised Open Label Clinical Trial
Speaker: Chris Tremonti, Sydney Local Health District, NSW
PO#268: An Open-Label, Multicentre, Single-Arm Trial Of Monthly Injections Of Extended Release Buprenorphine In People With Opioid Use Disorder: The Colab Study
Speaker: Michael Farrell, The University of New South West, NSW
PO#242: The Incidence Of Injecting-Related Diseases Among People Prescribed Opioid Agonist Treatment In New South Wales: A Retrospective Data Linkage Study Using Hospital Administration Data
Speaker: Samantha Colledge, NDARC, NSW
PO#346: Public Opioid Dispensary Clinic Clients And Their Use Of Health Services Pre And Post 2020 COVID-19 Restrictions In Sydney, NSW
Speaker: Sophia Little, Sydney Local Health District, NSW
PO#332: Evaluating Community Pharmacy Performance In The Medication Assisted Treatment For Opioid Dependence Program Based On Operational Activity And Pharmacist Reported Outcomes And Experiences
Speaker: Liam Elliott, University Of South Australia, SA
PO#295: “I Wouldn’t Know What To Do If They Cut Me Off”: Unique Barriers To Help Seeking In Consumers With Pharmaceutical Opioid Dependence
Speaker: Carina Walters, University of Auckland, NZ
PO#229: Client Experience Of Depot-Buprenorphine Two Years Post Implementation- Barriers To Treatment And Challenges Of COVID-19
Speaker: Sophia Little, Sydney Local Health District, NSW
PO#4: Association Of Opioid Agonist Treatment With All-Cause Mortality And Specific Causes Of Death Among People With Opioid Dependence: A Systematic Review And Meta-Analysis
Speaker: Thomas Santo Jr., National Drug & Alcohol Research Centre, Unsw Sydney, NSW
Opioids & Overdose
PO#344: Opioid Overdoses Attended By Ambulances Among People Who Inject Drugs: A Prospective Observational Study
Speaker: Kasun Rathnayake, Burnet Institute, VIC
PO#169: Recent Trends In The Availability Of, And Harms Related To, Prescription Opioids And Benzodiazepines In Australia
Speaker: Roberta Wang, Australian Institute of Health and Welfare, NSW
PO#297: Incidence Of Fatal And Non-Fatal Drug Overdose Among People With A History Of Opioid Dependence Increase In The First 4 Weeks Of Treatment Cessation: Retrospective Linkage Study
Speaker: Nicola Jones, National Drug and Alcohol Research Centre, NSW
PO#330: Assessment Of A Single-Item Opioid Craving Visual Analog Scale (OC-VAS) In Patients With Opioid Use Disorder
Speaker: Laura Johnston, Indivior, NSW
Peers
PO#291: Peer Work In The Age Of COVID: The SESLHD Drug And Alcohol Service Experience
Speaker: Brendan Crozier, The Langton Centre, NSW
PO#216: The Counselling Online Forum: Innovative Approaches To Build Peer Support And Online Connection For People Living With Addiction
Speaker: Annette Peart, Monash University, VIC
Performance and Image Enhancing Drugs
Presentation 1: The Push Audit – Design, Recruitment And The Role Of General Practitioners In Harm Reduction In The Non-Prescribed Performance And Image Enhancing Drugs Use Population
Speaker: Beng Eu, Prahran Market Clinic, VIC
Presentation 2: The Who, What, Why Of Performance And Image Enhancing Drugs Use And The Adverse Effects Reported: Data From The Push Audit
Speaker: Matthew Dunn, Deakin University, VIC
Presentation 3: Effects Of Anxiety And Depression On Adverse Health Outcomes And Harm Management Approaches Among People Who Use Nonprescribed Performance And Image Enhancing Drugs: Data From The Push Audit
Speaker: Joshua Dawe, Burnet Institute, VIC
Presentation 4: The Measured Adverse Effects Of Performance And Image Enhancing Drugs Use – What Is Real And What Is Over-Stated? Measured Adverse Effects Data From The Push Audit
Speaker: Beng Eu, Prahran Market Clinic, VIC
Policy & Law
Presentation 1: Policy Recommendations To Reduce Harms From Alcohol
Speaker: Jacqueline Bowden, The University Of Adelaide, SA
Presentation 2: Policy Recommendations To Reduce Harms From Other Drugs
Speaker: Shona Crabb, The University Of Adelaide, SA
Presentation 3: Alcohol And Other Drug Use Among Aboriginal And Torres Strait Islander Communities: Policy Responses To Reduce Harms
Speaker: Scott Wilson, Aboriginal Drug & Alcohol Council (SA) Aboriginal Corporation, SA
VP#153: Playing Research Cupid: Prioritising And Implementing Research And Evaluation With Policymakers, Academics, Clinicians And Consumers Using A Co-Creative Approach
Speaker: Lexi Buckfield, NSW Ministry Of Health, NSW
VP#23: Changes In Australian Drug Policy 1996-2016: How Did We Do?
Speaker: Annie Bleeker, Alcohol Tobacco And Other Drug Association Of The Act, NSW
VP#228: Community Attitudes To Laws On Personal Drug Use: Survey Of 4 NSW Electorates
Speaker: Alice Salomon, Uniting, NSW
PO#222: Substance Use And Violence: A Meta-Review
Speaker: Daniel Stjepanovic, The University Of Queensland, QLD
PO#152: Evidence That The Northern Territory’s Minimum Price Targets Heavy Alcohol Consumption
Speaker: Nicholas Taylor, Deakin University, VIC
PO#271: Exploring The Implications Of Data Protection Regulation For Online Alcohol Marketing
Speaker: Daniel Anderson-Luxford, Centre For Alcohol Policy Research, La Trobe University, VIC
PO#340: How Much Alcohol Would Be Affected By The Introduction Of A Minimum Unit Price In Western Australia? Findings From An Audit Of Alcohol Retail Prices
Speaker: Tina Lam, Monash Addiction Research Centre, VIC
PO#130: Rideshare Trips And Assaults At On-Premise Alcohol Outlets
Speaker: Christopher Morrison, Columbia University, USA
PO#121: Public Health And Public Participation: A Critical Comparison Of Liquor Licensing Legislation In Australia And The UK
Speaker: Filip Djordjevic, Centre for Alcohol Policy Research, VIC
Populations
VP#55: Information-Seeking Behaviours In A Sample Of Australian Chemsex Users
Speaker: Daniel Demant, School Of Public Health, Faculty Of Health, University Of Technology Sydney, NSW
VP#317: Social Inequalities In Harms From Others’ Drinking Across The World
Speaker: Anne-Marie Laslett, Centre For Alcohol Policy Research, La Trobe University, VIC
PO#378: The Ageing Population Of People Who Inject Drugs: Findings From The 2000-2021 Illicit Drug Reporting System
Speaker: Udesha Chandrasena, National Drug And Alcohol Research Centre, NSW
PO#81: CCan Education Programs Improve Construction Workers Alcohol And Drug Knowledge, Skills And Attitudes? Findings From A Non-Randomised Trial
Speaker: Ann Roche, Flinders University, SA
PO#47: Who We Are Helping: Describing Demographic, Health, And Social Factors Associated With Principal Drug Of Concern, Alcohol Use, And Alcohol-Related Harms, In The Australian Alcohol And Other Drug Treatment-Seeking Population
Speaker: Nathan Heijstee, Faculty of Medicine, University of NSW, NSW
PO#315: Associations Of Alcohol, Tobacco And Gambling Expenditure With Housing Affordability And Ownership In Australia
Speaker: Lamia Khandker, Centre for Alcohol Policy Research, La trobe University, VIC
PO#87: Breaking Down Barriers For Lesbian, Gay, Bisexual, Transgender And Queer (LGBTQ) People In A Tertiary Alcohol And Drug Treatment Service
Speaker: John Kelly, Metro North Mental Health – Alcohol And Drug Service, QLD
PO#12: Non-Prescription Drug Use Among HIV Positive Gay And Bisexual Men In Australia: A Latent Class Analysis With Sequela For Health And Well-Being
Speaker: Thomas Norman, La Trobe University, VIC
PO#189: Providing Information For The Health Workforce Relating To Aboriginal And Torres Strait Islander Substance Use And Contact With The Justice System
Speaker: Ashleigh Parnell, Australian Indigenous HealthInfoNet, WA
Prescribers & Clinicians
PO#61: Providing Access To Sensory Approaches Training For Alcohol And Other Drug Clinicians
Speaker: Michelle Taylor, Insight: Centre for alcohol and other drug training and workforce development, QLD
PO#325: Designing A Prospective, Multisite Implementation-Efficacy Trial Of A Collaborative Prescriber-Pharmacist Model For Medication Assisted Treatment For Opioid Dependence: The EPIC-MATOD Trial
Speaker: Suzanne Nielsen, Monash Addiction Research Centre, Monash University, VIC
PO#101: Upskilling, Downsizing. – The Lived Experience: Professional And Personal Reflections Of An AOD Career Change
Speaker: David Dwyer, KMHAOD, NT
PO#54: General Practitioner Perceptions Of E-Cigarettes For Smoking Cessation: A Systematic Review
Speaker: Melis Selamoglu, Monash University, VIC
PO#90: Oral Health Knowledge And Behaviours Of People Experiencing Alcohol And Other Drugs Dependence: A Potential Role Of AOD Clinicians In Promoting Oral Health
Speaker: Prakash Poudel, Drug Health Services, South Western Sydney Local Health District, NSW
PO#51: The Value Of Recordings In Clinical Supervision And Challenges Of Implementation
Speaker: Nicholas Kerswell, University Of Queensland, QLD
PO#95: Assessing The Research Capacity Of Staff From Alcohol And Other Drugs Treatment Services Based In NSW
Speaker: Robert Stirling, Network of Alcohol and Other Drugs, NSW
Prisoners’ Health
PO#44: Alcohol Relapse Prevention After Alcohol Withdrawal In Prisons Of New South Wales, Australia: A Retrospective Clinical File Audit
Speaker: Yichao Liang, Justice Health & Forensic Mental Health Network, NSW
PO#181: Health Service And Custodial Staff Acceptability Of Depot Buprenorphine In NSW Correctional Centres
Speaker: Sophia Little, Sydney Local Health District, NSW
PO#208: Depot Buprenorphine As An Opioid Agonist Therapy In New South Wales Correctional Centres: A Costing Model
Speaker: Bethany White, Sydney Local Health District, NSW
PO#191: Identification And Management Of Possible Alcohol Use Disorders Among Patients Entering Custody In New South Wales
Speaker: Jillian Roberts, Justice Justice Health and Forensic Mental Health Network, NSW
PO#313: Two-Year Reimprisonment Rate After First Adult Prison Episode Among Men With Who Inject Drugs
Speaker: Ashleigh Stewart, Burnet Institute, VIC
PO#159: Understanding How Long-Acting Depot Buprenorphine Impacts The High-Risk Post-Release Period- Protocol For The Release Study
Speaker: Adrian Dunlop, Sydney Local Health District, NSW
PO#86 A Novel Responsive Telehealth Intervention To Address Overdose Risk For People Recently Released From Prison – The ROADS (Released Offender Alcohol And Drug Support) Project
Speaker: Heidi Deifel-Carlino, Adis 24/7 Alcohol & Drug Support, QLD
Residential Rehab and NGO Treatment Settings
PO#221: Process And Challenges For Implementing A Brief Intervention As The First Step In A Community AOD Setting
Speaker: Leith Morris, University Of Queensland, QLD
PO#163: Nadabase: 10 Years Of Routine Outcomes Measurement (ROM) Data From The NSW Non Government Specialist Alcohol And Other Drug Treatment Sector
Speaker: Suzie Hudson, Nada, NSW
PO#356: Day-Rehabilitation Service As A Complimentary Treatment Option To Residential Services
Speaker: Erika Nel, Lives Lived Well, QLD
PO#131: GHB Withdrawal Admissions In An Australian Residential Detox
Speaker: Vicky Phan, Turning Point, VIC
PO#353: The Reliability Of Self-Report Assessments Of The ATOP And WHO ASSIST Compared With Standard Interviews In Residential Treatment For Substance Use Disorders
Speaker: Bronwyn Theroux, Griffith University, QLD
PO#333: Measuring Sleep-Wake Activity And Bedroom Environment In A Residential Treatment Setting: Acceptability And Feasibility Of Using Actigraphy And Environmental Data Loggers And Links With Recovery Outcomes
Speaker: Caroline Salom, The University of Queensland, QLD
PO#78: Does Housing Context Influence Social Identity Transition And Outcomes Of Therapeutic Community Treatment?
Speaker: Genevieve Dingle, University of Queensland, QLD
PO#277: The NSW Ministry Of Health Business And Funding Model Study: An Examination Of NGO AOD Treatment Costs And Implications For Future Business And Funding Models
Speaker: Joanne Ross, NSW Ministry Of Health, NSW
Stigma
PO#345: Understanding Stigma Towards Substance Use Among Migrant And Ethnic Minority Groups: A Qualitative Systematic Review
Speaker: Caitlin Douglass, Burnet Institute, VIC
PO#343: Key Principles For Minimising Stigmatising Language: A Thematic Analysis Of Alcohol And Other Drug-Related Language Guides
Speaker: Ramez Bathish, Monash University, VIC
PO#287: “You Learn About Stigma When You Start Treatment” – Health Workforce Attitudes, Beliefs And Behaviours Towards People Experiencing Harm From Alcohol And Other Drugs
Speaker: Marisa Ronsisvalle, NSW Ministry Of Health, NSW
Supervised Injecting Facilities
SYM#199 The Evolution Of Supervised Injecting Facilities In Australia – A Tale Of Three Cities
Presentation 1: Brief Introduction Of Supervised Injecting Facilities Internationally
Speaker: Amanda Roxburgh, Burnet Institute, VIC
Presentation 2: Uniting Medically Supervised Injecting Centre Celebrates 20th Birthday 2021, New South Wales
Speaker: Marianne Jauncey, Uniting MSIC, NSW
Presentation 3: Three Years Of Operation At The Medically Supervised Injecting Room In Victoria
Speaker: Nico Clark, North Richmond Community Health, VIC
Presentation 4: The Feasibility Of A Supervised Injecting Facility In The Australian Capital Territory
Speaker: Chris Gough
Discussant: Paul M. Dietze, National Drug Research Institute, VIC
PO#187: Improving Assessment And Management Of Suicide Risk At The Uniting Medically Supervised Injecting Centre, Sydney
Speaker: Kate Hocknull, Uniting MSIC, NSW
PO#342: Long-Acting Buprenorphine Injection Treatment Of Opioid Dependence In A Medically Supervised Injecting Room
Speaker: Nicolas Clark, North Richmond Community Health, VIC
Tobacco Cessation
VP#221: A Network Meta-Analysis Of Randomised Controlled Trial Evaluating The Effectiveness Of E-Cigarettes In Smoking Cessation
Speaker: Daniel Stjepanovic, The University Of Queensland, QLD
PO#115: Reasons For Using Electronic Cigarettes In 2016 And 2019 In Australia: A Repeated Cross-Sectional Study
Speaker: Ara Cho, The University Of Queensland, QLD
PO#267: Tobacco And Financial Hardship: A Systematic Review And Meta-Analysis Of Observational Research
Speaker: Rowan Dowling, Centre For Alcohol Policy Research, La Trobe University, VIC
PO#135: Patterns Of Cannabis And Tobacco Use In Australia: Latent Class Analysis And Health-Rated Correlates
Speaker: Carmen Lim, NCYSUR, QLD
PO#137: Predictors Of Reductions In Workers’ Daily Tobacco Smoking 2007-2016
Speaker: Alice McEntee, Flinders University, SA
PO#223: A Meta-Analysis Of The Efficacy Of Smokeless Tobacco For Smoking Cessation
Speaker: Daniel Stjepanovic, The University Of Queensland, QLD
PO#375: Can E-Cigarettes Assist Opiate Agonist Treatment Clients To Quit Smoking? Methods And Recruitment Data
Speaker: Emma Austin, Hunter New England LHD Drug and Alcohol Clinical Services, NSW
Technology Based Interventions
PO#215: Trial Of A Telephone-Delivered Intervention For Problem Alcohol Use (Ready2Change): Baseline Characteristics And A Latent Class Analysis Of Barriers To Alcohol Treatment
Speaker: Jasmin Grigg, Turning Point, UK
PO#48: How Well Can Your Smartphone Measure What You Drink And Smoke? Systematic Review Of Measurement Properties Of Smartphone Approaches To Assess Alcohol And Tobacco Use
Speaker: Louise Thornton, The Matilda Centre, The University Of Sydney, NSW
PO#26: The Regulation Of Technology Discourages Novelty And Holds Drug Health Service Back During COVID-19
Speaker: Meryem Jefferies, Western Sydney Local Health District Drug Health, NSW
Treatment & Treatment Settings
VP#176: Patient Characteristics And Psychological Factors As Predictors Of Treatment Completion In Residential Substance Use Treatment
Speaker: Calvert Tisdale, University Of Queensland, QLD
VP#102: Prevalence Of Common Mental Disorders Among People With Opioid Use Disorder: A Systematic Review And Meta-Analysis
Speaker: Thomas Santo Jr., National Drug & Alcohol Research Centre, UNSW Sydney, NSW
PO#34: Giving Clients A Voice: A Narrative Review Of Implementing Brief Client-Based Feedback Measures In Routine Practice
Speaker: Julie Dubuc, Kirketon Road Centre, NSW
PO#98: Retention Of Opioid Agonist Treatment Prescribers Across New South Wales, Australia, 2001-2018: Implications For Treatment Systems And Potential Impact On Client Outcomes
Speaker: Nicola Jones, National Drug and Alcohol Research Centre, NSW
PO#139: Treatment Characteristics Of Intensive Alcohol And Other Drug Treatment Service Use
Speaker: Willow Bryant, AIHW, ACT
PO#155: At One Click: Australian Online Collection Of Alcohol And Other Drug Screening And Withdrawal Tools
Speaker: Jane Fischer, National Centre for Education and Training on Addiction (NCETA), Flinders University, SA
PO#52: SCOT: Developing A Shared Care Model Of Service For Treatment Opioid Dependence From Conceptualisation To Implementation
Speaker: Tracey Veitch, Queensland Health, QLD
PO#183:Geographic Variations In Australian Drug And Alcohol Services Influence The Implementation Of The Pathways To Comorbidity Care (PCC) Program
Speaker: Kirsten Morley, The University of Sydney, NSW
PO#371: Does Health Literacy Change Over Time? A Longitudinal Examination Of The Health Literacy Of People Exiting Substance Use Disorder Treatment
Speaker: Tayla Degan, University Of Wollongong, NSW
PO#91: Reducing Barriers To Alcohol And Drug Treatment Through A Structured Brief Intervention Program Delivered By Adis 24/7 Alcohol And Drug Support
Speaker: Kiara Palmer, Adis 24/7 Alcohol And Drug Support, QLD
PO#113: Screening For Risky Substance Use In Emergency Department Presentations: A Pilot Investigation Of ASSIST-Lite To Investigate The Characteristics Of Substance Users Attending The Royal Adelaide Hospital
Speaker: Matthew Stevens, University Of Adelaide, SA
PO#170: Eye Movement Desensitisation And Reprocessing (EMDR) – Impact On Substances Use: A Literature Review
Speaker: Maryanne Robinson, NSW Health – Hunter New England LHD – Drug and Alcohol Clinical Services, NSW
PO#370: Does Health Literacy Change Over Time? A Longitudinal Examination Of The Health Literacy Of People Exiting Substance Use Disorder Treatment
Speaker: Melvin Goh, University Of Wollongong, NSW
PO#206: The NSW Clinical Care Standards: AOD Treatment. Resources Developed To Support The Implementation
Speaker: Kristie Mammen, SESLHD, NSW
PO#179: Prevention, Assessment, And Management Of Suicidality In Clients Attending Drug And Alcohol Services
Speaker: Brennan Geiger, Black Dog Institute, USYD Speciality of Addiction Medicine, Kirketon Road Centre SESLHD, NSW
PO#374: The DACRIN Data Project: A Process For Harmonising Data Collection Across Aod Services In NSW
Speaker: Lauren Monds, University Of Sydney, NSW
Speaker: Charlotte Ismay, Drug And Alcohol Clinical Services, Newcastle, NSW
Women and Maternal Issues
PO#106: Hospital Admissions For Vomiting Among Pregnant Women Who Self-Reported Non-Medicinal Cannabis Use
Speaker: Siyu Qian, Drug And Alcohol Service, Illawarra Shoalhaven Local Health District, NSW
PO#136: Reducing Unintended Pregnancy: Drug And Alcohol Services Pregnancy Intention And Contraception Project
Speaker: Vicki Chase, Central Coast Local Health District, NSW
PO#308: Systematic Review And Meta-Analytic Review Of Longitudinal Studies On The Association Of Substance Use In Breastfeeding Women With Maternal Lactation And Child Development
Speaker: Delyse Hutchinson, Deakin University, VIC
PO#264: Clinical Indicators For Substance Use In Pregnancy And Parenting Services: A Scoping Review
Speaker: Sharon Reid, DHS, RPAH, Sydney Local Health District, NSW
PO#149: A Systematic Review And Meta-Analysis Of Eating Disorder Prevalence Among Women In Treatment For Substance Use
Speaker: Laura Robinson, School Of Psychology, University Of Wollongong, NSW
Workforce
SYM#275: What Works In The Workplace? Alcohol And Other Drug Interventions For Employees
Presentation 1: Introduction To The Workplace As An Intervention Setting
Speaker: Ann M. Roche, Flinders University, SA
Presentation 2: A The Effectiveness Of Workplacebased Interventions For Alcohol And Other Drug Use
Speaker: Ashleigh K. Morse, The University Of Sydney, NSW
Presentation 3: Workplace Alcohol And Drug Testing: What Is The Latest Evidence On Its Effectiveness?
Speaker: Ann M. Roche, Flinders University, SA
Presentation 4: Employees Views Regarding Barriers And Facilitators To Accessing Workplace-Based Alcohol And Other Drug Interventions
Speaker: Jayden Sercombe, The Matilda Centre, NSW
Presentation 5: Identifying Future Directions For Workplace Studies Of Alcohol And Other Drug Use
Speaker: Ann M. Roche, Flinders University, SA
PO#31: Identifying Perceived Barriers And Facilitators To Accessing Effective Clinical Supervision And The Implementation Of A Clinical Supervision Exchange Model In The Alcohol And Other Drug Sector
Speaker: Courtney O’Donnell, Qnada, QLD
PO#251: Workplace Alcohol And Other Drug Interventions: An Overview Of Reviews
Speaker: Vinita Duraisingam, NCETA, WA